PMID: 42577069

Orforglipron for obesity treatment in older patients ≥65 years with or without type 2 diabetes: A post hoc subgroup analysis of the ATTAIN-1 and ATTAIN-2 trials.

Horn Deborah B, Shukla Alpana P, Huang Haocheng, Twum Elvis, Allen Sheryl Elaine, Kis Sanja Giljanovic

Obesity pillars · 2026

Vol. 19, pp. 100301

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.

Orforglipron for obesity treatment in older patients &#x2265;65&#x202f;years with or without type 2 diabetes: A post hoc subgroup analysis of the ATTAIN-1 and ATTAIN-2 trials.